Max Healthcare Q1 FY27 results: revenue up 17% YoY, Rs 425 Cr capex for Vaishali expansion
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts more than Nifty 100 and 1.3 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Max Healthcare reported Q1 FY27 consolidated revenue of Rs 2,366 crore, up about 17% YoY from Rs 2,028 crore. PAT rose around 5% to Rs 323 crore, EPS at Rs 3.32. Auditor issued an unmodified review report. Board approved Rs 425 crore capex for Tower 3 at Vaishali hospital, adding about 202 beds by November 2029. Two senior management appointments and one resignation announced. In-principle approval given to explore medical colleges.
Steady revenue growth, clean audit, and expansion capex signal continued business momentum. No exceptional items this quarter.